A Study to Evaluate Decision-support Interventions for Atrial Fibrillation (RED-AF)


About this study

  1. The primary purpose of this study is to assess the comparative effectiveness of the following 4 approaches to promote high-quality SDM for at-risk patients with AF:  a PDA alone, (2) an EDA alone, (3) a combination of a PDA and an EDA, and (4) control with neither a PDA nor an EDA.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults 18 and older who have an appointment with their clinician in which stroke prevention strategies for Atrial Fibrillation will likely be discussed.
  • Patients diagnosed with Atrial Fibrillation.
  • Patients who are aware they have been diagnosed with Atrial Fibrillation.
  • Patients with additional risk of thromboembolic events (CHA2DS2-VASc scores ≥ 1 in men and ≥ 2 inwomen).

Exclusion Criteria:

  • Patients deemed by their clinician or research personnel to be ineligible for consideration of taking or of foregoing anticoagulation.
  • Patients who
  • have deficits in cognitive abilities, sensory input, or language significant enough to impede shared decision making and/or the provision of written informed consent.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Victor Montori, M.D.

Open for enrollment

Contact information:

Angela Sivly CCRP



More information


Publications are currently not available

Mayo Clinic Footer